ImpactOS
See an example

Illumina, Inc

Companies and groups · United States

In these lists: Medicines

Declared lobbying cost
€900,000 – €999,999 Financial year 01/2025-12/2025
Commission meetings
3
Full-time staff on EU lobbying
1.25
European Parliament access passes
2
Registered since
11 Mar 2016
Public records onlyWhat this means

Every profile, record and figure comes from documents published by EU institutions, national authorities, courts, ethics bodies, the EU Transparency Register or established news outlets. We use no leaks, private data or anonymous tips. AI helps us gather and cross-check sources but never decides anyone's guilt: each record keeps its exact legal status and links to its source, so you can check it yourself

Registering is a legal transparency duty, not a sign of wrongdoing. Budgets and meetings show access, not influence on any particular decision. Register figures as declared on 30 Jun 2026

Fields of interest

Agriculture and rural development, Budget, Competition, Food safety, Institutional affairs, Public health, Research and innovation, Trans-European Networks

Medicines and food topics they name

Orphan and paediatric medicine incentives, Antibiotics and antimicrobials

EU laws and policies they declare following4
  • Illumina follows policy and legislative developments related to genomics, agri-genomics, public health, animal health, agriculture, forensics, biotechnology, data protection, science, and research po…
  • In particular, Illumina follows the discussions on the proposal for a EU Health Data Space (EHDS) and developments relating to the Regulations on medical devices (MDR) and In-vitro diagnostics (IVDR)…
  • Additionally, Illumina focuses on policy developments related to the Beating Cancer Plan, the 1+Million Genomes Initiative, the EU Action on Antimicrobial Resistance (AMR), the EU Covid-19 policy res…
  • Moreover, an emphasis is also given to monitoring the review in scope and responsibilities of key institutional stakeholders such as the European Medicine Agency (EMA), the European Center for Diseas…

Meetings with the Commission

Meetings with Commissioners or their Cabinets since 1 December 2024, as the Commission publishes them

  1. With the Cabinet

    Ursula von der Leyen

    To give an update of recent development in the company and sector

    Published record
  2. With the Cabinet

    Ekaterina Zaharieva

    Exchange on Life Sciences Strategy and next Framework Programme

    Published record
  3. With the Cabinet

    Stéphane Séjourné

    Genomic research in Europe

    Published record

Official entries

Name in the register: Illumina, Inc.

Checked against sources on 11 Nov 2026